Mariam O. Fofana, MD, PhD
Postdoctoral Fellow
Research & Publications
Biography
Coauthors
Selected Publications
- Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysisLind M, Robertson A, Silva J, Warner F, Coppi A, Price N, Duckwall C, Sosensky P, Di Giuseppe E, Borg R, Fofana M, Ranzani O, Dean N, Andrews J, Croda J, Iwasaki A, Cummings D, Ko A, Hitchings M, Schulz W. Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis. PLOS Medicine 2022, 19: e1004136. PMID: 36454733, PMCID: PMC9714718, DOI: 10.1371/journal.pmed.1004136.
- Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional surveyFofana MO, Nery N, Ticona J, de Andrade Belitardo EMM, Victoriano R, Anjos RO, Portilho MM, de Santana MC, dos Santos LL, de Oliveira D, Cruz JS, Muenker MC, Khouri R, Wunder EA, Hitchings MDT, Johnson O, Reis MG, Ribeiro GS, Cummings DAT, Costa F, Ko AI. Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey. PLOS Medicine 2022, 19: e1004093. PMID: 36074784, PMCID: PMC9499230, DOI: 10.1371/journal.pmed.1004093.
- Reliable estimation of SARS-CoV-2 anti-spike protein IgG titers from single dilution optical density values in serologic surveysBelitardo E, Nery N, Ticona J, Portilho MM, Mello IO, Ribeiro GS, Reis MG, Costa F, Cummings DAT, Ko AI, Fofana MO. Reliable estimation of SARS-CoV-2 anti-spike protein IgG titers from single dilution optical density values in serologic surveys. Diagnostic Microbiology And Infectious Disease 2022, 104: 115807. PMID: 36162285, PMCID: PMC9428330, DOI: 10.1016/j.diagmicrobio.2022.115807.
- The Deepest CutsFofana MO. The Deepest Cuts. Annals Of Emergency Medicine 2021, 78: 453-454. PMID: 34420558, DOI: 10.1016/j.annemergmed.2021.03.011.
- Willingness to Get the COVID-19 Vaccine among Residents of Slum SettlementsTicona J, Nery N, Victoriano R, Fofana MO, Ribeiro GS, Giorgi E, Reis MG, Ko AI, Costa F. Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements. Vaccines 2021, 9: 951. PMID: 34579188, PMCID: PMC8472908, DOI: 10.3390/vaccines9090951.
- Racial Discrimination from Patients: Institutional Strategies to Establish Respectful Emergency Department EnvironmentsChary A, Fofana M, Kohli H. Racial Discrimination from Patients: Institutional Strategies to Establish Respectful Emergency Department Environments. Western Journal Of Emergency Medicine 2021, 22: 898-902. PMID: 35354011, PMCID: PMC8328184, DOI: 10.5811/westjem.2021.3.51582.
- Time and time again: the reincarnations of coerced sterilisationFofana MO. Time and time again: the reincarnations of coerced sterilisation. Journal Of Medical Ethics 2021, 48: 805-809. PMID: 34127527, DOI: 10.1136/medethics-2020-106924.
- Decolonising global health in the time of COVID-19Fofana MO. Decolonising global health in the time of COVID-19. Global Public Health 2020, 16: 1155-1166. PMID: 33370211, DOI: 10.1080/17441692.2020.1864754.
- Reply to Anthony et al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment”Fofana M, Dowdy D. Reply to Anthony et al., “Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment”. Antimicrobial Agents And Chemotherapy 2017, 61: e00427-17. PMID: 28539499, PMCID: PMC5444152, DOI: 10.1128/aac.00427-17.
- A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant TuberculosisFofana MO, Shrestha S, Knight GM, Cohen T, White RG, Cobelens F, Dowdy DW. A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis. Antimicrobial Agents And Chemotherapy 2017, 61: e00498-16. PMID: 27956422, PMCID: PMC5328532, DOI: 10.1128/aac.00498-16.
- Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysisKendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. The Lancet Respiratory Medicine 2015, 3: 963-972. PMID: 26597127, PMCID: PMC4684734, DOI: 10.1016/s2213-2600(15)00458-0.
- The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based AnalysisKnight GM, Colijn C, Shrestha S, Fofana M, Cobelens F, White RG, Dowdy DW, Cohen T. The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis. Clinical Infectious Diseases 2015, 61: s147-s154. PMID: 26409276, PMCID: PMC4583567, DOI: 10.1093/cid/civ579.
- Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiativeMoran D, Edwardson J, Cuneo CN, Tackett S, Aluri J, Kironji A, Cox J, Carroll B, Lie E, Fofana M, Bollinger RC, Ziegelstein RC, Chen CC. Development of global health education at Johns Hopkins University School of Medicine: a student-driven initiative. Medical Education Online 2015, 20: 28632. PMID: 26220909, PMCID: PMC4518163, DOI: 10.3402/meo.v20.28632.
- Gaps in predeparture training and postexperience debriefing in global health experiences: A survey of health professions studentsKironji A, Aluri J, Decamp M, Carroll B, Cox J, Fofana M, Lie E, Moran D, Tackett S, Chen C. Gaps in predeparture training and postexperience debriefing in global health experiences: A survey of health professions students. Annals Of Global Health 2014, 80: 166-167. DOI: 10.1016/j.aogh.2014.08.031.
- Drivers and Trajectories of Resistance to New First-Line Drug Regimens for TuberculosisShrestha S, Knight GM, Fofana M, Cohen T, White RG, Cobelens F, Dowdy DW. Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis. Open Forum Infectious Diseases 2014, 1: ofu073. PMID: 25734143, PMCID: PMC4281792, DOI: 10.1093/ofid/ofu073.
- Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based AnalysisFofana MO, Knight GM, Gomez GB, White RG, Dowdy DW. Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis. PLOS ONE 2014, 9: e96389. PMID: 24816692, PMCID: PMC4015982, DOI: 10.1371/journal.pone.0096389.
- The spectre of race in American medicineFofana MO. The spectre of race in American medicine. Medical Humanities 2013, 39: 137. PMID: 23988563, PMCID: PMC4131435, DOI: 10.1136/medhum-2013-010374.
- 2012 Winning EssayFofana M. 2012 Winning Essay. The AMA Journal Of Ethic 2013, 15: 653-659. PMID: 23937779, DOI: 10.1001/virtualmentor.2013.15.8.conl1-1308.
- Cost-effectiveness of novel first-line treatment regimens for tuberculosisOwens JP, Fofana MO, Dowdy DW. Cost-effectiveness of novel first-line treatment regimens for tuberculosis. The International Journal Of Tuberculosis And Lung Disease 2013, 17: 590-596. PMID: 23575322, PMCID: PMC3844288, DOI: 10.5588/ijtld.12.0776.
- The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South AfricaWalensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD. The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2011, 56: 26-35. PMID: 21068674, PMCID: PMC3005842, DOI: 10.1097/qai.0b013e3181fb8f24.
- When to start antiretroviral therapy in resource-limited settings.Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E. When to start antiretroviral therapy in resource-limited settings. Annals Of Internal Medicine 2009, 151: 157-66. PMID: 19620143, PMCID: PMC3092478, DOI: 10.7326/0003-4819-151-3-200908040-00138.
- Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on SurvivalWalensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA. Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival. The Journal Of Infectious Diseases 2008, 197: 1324-1332. PMID: 18422445, PMCID: PMC2423492, DOI: 10.1086/587184.